Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Profit After Tax (2016 - 2025)

Palisade Bio (PALI) has disclosed Profit After Tax for 16 consecutive years, with -$2.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Profit After Tax rose 17.75% to -$2.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$11.2 million, a 20.18% increase, with the full-year FY2024 number at -$14.4 million, down 17.38% from a year prior.
  • Profit After Tax was -$2.9 million for Q3 2025 at Palisade Bio, down from -$2.8 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $13.4 million in Q4 2022 to a low of -$31.7 million in Q2 2021.
  • A 5-year average of -$4.0 million and a median of -$3.4 million in 2023 define the central range for Profit After Tax.
  • Peak YoY movement for Profit After Tax: crashed 1615.07% in 2021, then skyrocketed 92.62% in 2022.
  • Palisade Bio's Profit After Tax stood at -$31.7 million in 2021, then skyrocketed by 142.3% to $13.4 million in 2022, then crashed by 122.12% to -$3.0 million in 2023, then dropped by 12.55% to -$3.3 million in 2024, then increased by 14.23% to -$2.9 million in 2025.
  • Per Business Quant, the three most recent readings for PALI's Profit After Tax are -$2.9 million (Q3 2025), -$2.8 million (Q2 2025), and -$2.2 million (Q1 2025).